Cargando…
Peripheral Hybrid CB(1)R and iNOS Antagonist MRI-1867 Displays Anti-Fibrotic Efficacy in Bleomycin-Induced Skin Fibrosis
Scleroderma, or systemic sclerosis, is a multi-organ connective tissue disease resulting in fibrosis of the skin, heart, and lungs with no effective treatment. Endocannabinoids acting via cannabinoid-1 receptors (CB(1)R) and increased activity of inducible NO synthase (iNOS) promote tissue fibrosis...
Autores principales: | Zawatsky, Charles N., Park, Joshua K., Abdalla, Jasmina, Kunos, George, Iyer, Malliga R., Cinar, Resat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8505776/ https://www.ncbi.nlm.nih.gov/pubmed/34650521 http://dx.doi.org/10.3389/fendo.2021.744857 |
Ejemplares similares
-
Effects of a Peripherally Restricted Hybrid Inhibitor of CB1 Receptors and iNOS on Alcohol Drinking Behavior and Alcohol-Induced Endotoxemia
por: Santos-Molina, Luis, et al.
Publicado: (2021) -
CB(1)R and iNOS are distinct players promoting pulmonary fibrosis in Hermansky–Pudlak syndrome
por: Cinar, Resat, et al.
Publicado: (2021) -
Functional Selectivity of a Biased Cannabinoid-1
Receptor (CB(1)R) Antagonist
por: Liu, Ziyi, et al.
Publicado: (2021) -
Cholesterol as a modulator of cannabinoid receptor CB(2) signaling
por: Yeliseev, Alexei, et al.
Publicado: (2021) -
Dual inhibition of cannabinoid CB(1) receptor and inducible NOS attenuates obesity‐induced chronic kidney disease
por: Udi, Shiran, et al.
Publicado: (2019)